BR9106595A - Composicao aerossol pressurizada - Google Patents

Composicao aerossol pressurizada

Info

Publication number
BR9106595A
BR9106595A BR919106595A BR9106595A BR9106595A BR 9106595 A BR9106595 A BR 9106595A BR 919106595 A BR919106595 A BR 919106595A BR 9106595 A BR9106595 A BR 9106595A BR 9106595 A BR9106595 A BR 9106595A
Authority
BR
Brazil
Prior art keywords
surfactant
propellant
aerosol composition
pressurized aerosol
medicament
Prior art date
Application number
BR919106595A
Other languages
English (en)
Inventor
Asit Somani
Clive Booles
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909014526A external-priority patent/GB9014526D0/en
Priority claimed from GB909014527A external-priority patent/GB9014527D0/en
Priority claimed from GB909023953A external-priority patent/GB9023953D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of BR9106595A publication Critical patent/BR9106595A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
BR919106595A 1990-06-29 1991-06-25 Composicao aerossol pressurizada BR9106595A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB909014526A GB9014526D0 (en) 1990-06-29 1990-06-29 Aerosol formulation
GB909014527A GB9014527D0 (en) 1990-06-29 1990-06-29 Aerosol formulation
GB909023953A GB9023953D0 (en) 1990-11-03 1990-11-03 Pharmaceutical composition
PCT/GB1991/001023 WO1992000061A1 (en) 1990-06-29 1991-06-25 Pressurised aerosol compositions

Publications (1)

Publication Number Publication Date
BR9106595A true BR9106595A (pt) 1993-04-20

Family

ID=27265168

Family Applications (1)

Application Number Title Priority Date Filing Date
BR919106595A BR9106595A (pt) 1990-06-29 1991-06-25 Composicao aerossol pressurizada

Country Status (21)

Country Link
US (1) US5846521A (pt)
EP (1) EP0536235B1 (pt)
JP (1) JP2854974B2 (pt)
AT (1) ATE147973T1 (pt)
AU (1) AU8055691A (pt)
BR (1) BR9106595A (pt)
CA (1) CA2085884C (pt)
CZ (1) CZ392592A3 (pt)
DE (1) DE69124374T2 (pt)
DK (1) DK0536235T3 (pt)
ES (1) ES2096653T3 (pt)
FI (1) FI925852A0 (pt)
GR (1) GR3023065T3 (pt)
HU (1) HUT63554A (pt)
IE (1) IE912220A1 (pt)
MX (1) MX9100008A (pt)
NO (1) NO924954D0 (pt)
NZ (1) NZ238746A (pt)
PT (1) PT98133A (pt)
SK (1) SK392592A3 (pt)
WO (1) WO1992000061A1 (pt)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5766573A (en) * 1988-12-06 1998-06-16 Riker Laboratories, Inc. Medicinal aerosol formulations
US5785952A (en) * 1990-11-09 1998-07-28 Glaxo Group Limited Aerosol medicament formulation having a surface coating of surfactant
HUT67449A (en) * 1991-06-10 1995-04-28 Schering Corp Aerosol formulations containing 1,1,1,2,3,3,3-heptafluoropropane
CZ271393A3 (en) 1991-06-10 1994-07-13 Schering Corp Aerosol preparations without chlorofluorinated hydrocarbons
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
ATE171865T1 (de) 1991-12-12 1998-10-15 Glaxo Group Ltd Arzneimittel
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US5376359A (en) * 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
MX9304585A (es) * 1992-07-31 1994-03-31 Glaxo Group Ltd Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata.
AU679511B2 (en) * 1993-03-17 1997-07-03 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
JPH08507792A (ja) * 1993-03-17 1996-08-20 ミネソタ マイニング アンド マニュファクチャリング カンパニー ジオール−二酸から誘導される分散助剤を含むエーロゾル配合物
US5593661A (en) * 1993-03-29 1997-01-14 Henry; Richard A. Lidocaine aerosol anaesthetic
CA2176249C (en) * 1993-12-02 2010-06-01 Akwete L. Adjei Aerosol drug formulations for use with non-cfc propellants
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5635159A (en) * 1994-08-26 1997-06-03 Abbott Laboratories Aerosol drug formulations containing polyglycolyzed glycerides
US5635161A (en) * 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
WO1998034595A1 (de) 1997-02-05 1998-08-13 Jago Research Ag Medizinische aerosolformulierungen
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
GB9805938D0 (en) 1998-03-19 1998-05-13 Glaxo Group Ltd Valve for aerosol container
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
ATE283033T1 (de) 1998-07-24 2004-12-15 Jago Res Ag Medizinische aerosolformulierungen
CN1150890C (zh) 1998-08-04 2004-05-26 杰格研究股份公司 药用气溶胶制剂
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US6451287B1 (en) 2000-05-26 2002-09-17 Smithkline Beecham Corporation Fluorinated copolymer surfactants and use thereof in aerosol compositions
EP1318973A2 (en) 2000-09-22 2003-06-18 Glaxo Group Limited Novel alkanoic acid derivatives
WO2002053190A2 (en) 2000-12-29 2002-07-11 Advanced Inhalation Research, Inc. Particles for inhalation having sustained release properties
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
GB0125127D0 (en) 2001-10-19 2001-12-12 Glaxo Group Ltd Compounds
ATE508735T1 (de) 2001-12-19 2011-05-15 Novartis Ag Pulmonale verabreichung von aminoglykosiden
EP1458357B1 (en) * 2001-12-21 2009-03-04 3M Innovative Properties Company Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient
IL162752A0 (en) 2002-02-13 2005-11-20 Glaxo Group Ltd Carboxylic acid compounds for use as surfactants
GB0205327D0 (en) * 2002-03-06 2002-04-17 Glaxo Group Ltd compounds
WO2005016410A2 (en) 2003-08-11 2005-02-24 Glaxo Group Limited Pharmaceutical metered dose inhaler and methods relating thereto
US20080190418A1 (en) 2003-08-29 2008-08-14 Glaxo Group Limited Pharmaceutical Metered Dose Inhaler and Methods Relating Thereto
PL2425820T3 (pl) 2007-02-11 2015-08-31 Map Pharmaceuticals Inc Sposób terapeutycznego stosowania dhe w celu umożliwienia szybkiego złagodzenia migreny przy jednoczesnym zminimalizowaniu profilu działań niepożądanych
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
WO2016018892A1 (en) 2014-07-29 2016-02-04 3M Innovative Properties Company Method of preparing a pharmaceutical composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7708731A (nl) * 1976-08-13 1978-02-15 Montedison Spa Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen.
CA1136547A (en) * 1979-03-08 1982-11-30 Song-Ling Lin Aerosol anesthetic compositions
GB8432063D0 (en) * 1984-12-19 1985-01-30 Riker Laboratories Inc Physically modified steroids
EP0309519B1 (en) * 1987-04-09 1992-07-08 FISONS plc Pharmaceutical compositions containing pentamidine
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828544D0 (en) * 1988-12-07 1989-01-11 Ici Plc Chemical process
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
GB8908250D0 (en) * 1989-04-12 1989-05-24 Fisons Plc Formulations
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate

Also Published As

Publication number Publication date
MX9100008A (es) 1992-02-03
AU8055691A (en) 1992-01-23
DE69124374D1 (de) 1997-03-06
GR3023065T3 (en) 1997-07-30
JP2854974B2 (ja) 1999-02-10
IE912220A1 (en) 1992-01-01
ATE147973T1 (de) 1997-02-15
NO924954L (no) 1992-12-21
NO924954D0 (no) 1992-12-21
WO1992000061A1 (en) 1992-01-09
CA2085884C (en) 2001-12-04
HUT63554A (en) 1993-09-28
SK392592A3 (en) 1994-07-06
DK0536235T3 (da) 1997-04-14
EP0536235B1 (en) 1997-01-22
FI925852A (fi) 1992-12-23
ES2096653T3 (es) 1997-03-16
EP0536235A1 (en) 1993-04-14
CZ392592A3 (en) 1993-05-12
DE69124374T2 (de) 1997-06-19
FI925852A0 (fi) 1992-12-23
US5846521A (en) 1998-12-08
NZ238746A (en) 1992-10-28
PT98133A (pt) 1992-04-30
HU9204098D0 (en) 1993-03-29
CA2085884A1 (en) 1991-12-30
JPH05507712A (ja) 1993-11-04

Similar Documents

Publication Publication Date Title
BR9106595A (pt) Composicao aerossol pressurizada
ES2075956T3 (es) Composiciones propelentes.
MY110232A (en) Binary azeotropic compositions of (cf3chfchfch2cf3) with methanol or ethanol or isopropanol.
NO990454L (no) Aerosol-materiale
DE69418342D1 (de) Neue schaumzusammensetzungen, insbesondere zur rektalen anwendung, sowie davon erhaltene schäume
PE30399A1 (es) Producto para pulverizar sobre el cabello
BG102689A (en) Pharmaceutical aerosol composition
DE69726457D1 (de) Pharmazeutische zusammensetzungen mit antimikrobieller wirkung
CA2062779A1 (en) Sterilizing gas composition comprising monochlorotetrafluorethane and ethylene oxide
CA2176458A1 (en) Foaming Agent for Leave-On Foaming Cosmetic Compositions
JPS51116185A (en) An aerosol composition
MY107927A (en) Prewash cleaner compositions
ATE115395T1 (de) Haarspray-zusammensetzung.
ES2087036A1 (es) Pomada de accion rapida contra las varices.
RU92016480A (ru) Аэрозольные композиции, содержащие лекарственный препарат
ES2091008T3 (es) Agente para el cuidado del cabello.

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal